Table of Contents Chapter 1 Overview of Angiotensin II Receptor 1.1 Definition of Angiotensin II Receptor in This Report 1.2 Commercial Types of Angiotensin II Receptor 1.2.1 C-21 1.2.2 EMA-401 1.2.3 KDT-501 1.2.4 MOR-107 1.2.5 Others 1.3 Downstream Application of Angiotensin II Receptor 1.3.1 Immunology 1.3.2 Respiratory 1.3.3 Women's Health 1.3.4 Acute Ischemic Stroke 1.3.5 Others 1.4 Development History of Angiotensin II Receptor 1.5 Market Status and Trend of Angiotensin II Receptor 2013-2023 1.5.1 Europe Angiotensin II Receptor Market Status and Trend 2013-2023 1.5.2 Regional Angiotensin II Receptor Market Status and Trend 2013-2023 Chapter 2 Europe Market Status and Forecast by Regions 2.1 Market Status of Angiotensin II Receptor in Europe 2013-2017 2.2 Consumption Market of Angiotensin II Receptor in Europe by Regions 2.2.1 Consumption Volume of Angiotensin II Receptor in Europe by Regions 2.2.2 Revenue of Angiotensin II Receptor in Europe by Regions 2.3 Market Analysis of Angiotensin II Receptor in Europe by Regions 2.3.1 Market Analysis of Angiotensin II Receptor in Germany 2013-2017 2.3.2 Market Analysis of Angiotensin II Receptor in United Kingdom 2013-2017 2.3.3 Market Analysis of Angiotensin II Receptor in France 2013-2017 2.3.4 Market Analysis of Angiotensin II Receptor in Italy 2013-2017 2.3.5 Market Analysis of Angiotensin II Receptor in Spain 2013-2017 2.3.6 Market Analysis of Angiotensin II Receptor in Benelux 2013-2017 2.3.7 Market Analysis of Angiotensin II Receptor in Russia 2013-2017 2.4 Market Development Forecast of Angiotensin II Receptor in Europe 2018-2023 2.4.1 Market Development Forecast of Angiotensin II Receptor in Europe 2018-2023 2.4.2 Market Development Forecast of Angiotensin II Receptor by Regions 2018-2023 Chapter 3 Europe Market Status and Forecast by Types 3.1 Whole Europe Market Status by Types 3.1.1 Consumption Volume of Angiotensin II Receptor in Europe by Types 3.1.2 Revenue of Angiotensin II Receptor in Europe by Types 3.2 Europe Market Status by Types in Major Countries 3.2.1 Market Status by Types in Germany 3.2.2 Market Status by Types in United Kingdom 3.2.3 Market Status by Types in France 3.2.4 Market Status by Types in Italy 3.2.5 Market Status by Types in Spain 3.2.6 Market Status by Types in Benelux 3.2.7 Market Status by Types in Russia 3.3 Market Forecast of Angiotensin II Receptor in Europe by Types Chapter 4 Europe Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Angiotensin II Receptor in Europe by Downstream Industry 4.2 Demand Volume of Angiotensin II Receptor by Downstream Industry in Major Countries 4.2.1 Demand Volume of Angiotensin II Receptor by Downstream Industry in Germany 4.2.2 Demand Volume of Angiotensin II Receptor by Downstream Industry in United Kingdom 4.2.3 Demand Volume of Angiotensin II Receptor by Downstream Industry in France 4.2.4 Demand Volume of Angiotensin II Receptor by Downstream Industry in Italy 4.2.5 Demand Volume of Angiotensin II Receptor by Downstream Industry in Spain 4.2.6 Demand Volume of Angiotensin II Receptor by Downstream Industry in Benelux 4.2.7 Demand Volume of Angiotensin II Receptor by Downstream Industry in Russia 4.3 Market Forecast of Angiotensin II Receptor in Europe by Downstream Industry Chapter 5 Market Driving Factor Analysis of Angiotensin II Receptor 5.1 Europe Economy Situation and Trend Overview 5.2 Angiotensin II Receptor Downstream Industry Situation and Trend Overview Chapter 6 Angiotensin II Receptor Market Competition Status by Major Players in Europe 6.1 Sales Volume of Angiotensin II Receptor in Europe by Major Players 6.2 Revenue of Angiotensin II Receptor in Europe by Major Players 6.3 Basic Information of Angiotensin II Receptor by Major Players 6.3.1 Headquarters Location and Established Time of Angiotensin II Receptor Major Players 6.3.2 Employees and Revenue Level of Angiotensin II Receptor Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Angiotensin II Receptor Major Manufacturers Introduction and Market Data 7.1 CJ HealthCare Corp 7.1.1 Company profile 7.1.2 Representative Angiotensin II Receptor Product 7.1.3 Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of CJ HealthCare Corp 7.2 MorphoSys AG 7.2.1 Company profile 7.2.2 Representative Angiotensin II Receptor Product 7.2.3 Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of MorphoSys AG 7.3 Novartis AG 7.3.1 Company profile 7.3.2 Representative Angiotensin II Receptor Product 7.3.3 Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of Novartis AG 7.4 Vicore Pharma AB 7.4.1 Company profile 7.4.2 Representative Angiotensin II Receptor Product 7.4.3 Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of Vicore Pharma AB Chapter 8 Upstream and Downstream Market Analysis of Angiotensin II Receptor 8.1 Industry Chain of Angiotensin II Receptor 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Angiotensin II Receptor 9.1 Cost Structure Analysis of Angiotensin II Receptor 9.2 Raw Materials Cost Analysis of Angiotensin II Receptor 9.3 Labor Cost Analysis of Angiotensin II Receptor 9.4 Manufacturing Expenses Analysis of Angiotensin II Receptor Chapter 10 Marketing Status Analysis of Angiotensin II Receptor 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of C-21 Table Advantage and Disadvantage of EMA-401 Table Advantage and Disadvantage of KDT-501 Table Advantage and Disadvantage of MOR-107 Table Advantage and Disadvantage of Others Table Consumption Volume of Angiotensin II Receptor in Europe by Regions 2013-2017 Table Revenue of Angiotensin II Receptor in Europe by Regions 2013-2017 Table Consumption Volume of Angiotensin II Receptor in Europe by Regions 2018-2023 Table Revenue of Angiotensin II Receptor in Europe by Regions 2018-2023 Table Consumption Volume of Angiotensin II Receptor in Europe by Types 2013-2017 Table Revenue of Angiotensin II Receptor in Europe by Types 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in Germany 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in United Kingdom 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in France 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in Italy 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in Spain 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in Benelux 2013-2017 Table Consumption Volume of Angiotensin II Receptor by Types in Russia 2013-2017 Table Consumption Volume Forecast of Angiotensin II Receptor in Europe by Types 2018-2023 Table Revenue Forecast of Angiotensin II Receptor in Europe by Types 2018-2023 Table Demand Volume of Angiotensin II Receptor in Europe by Downstream Industry 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in Germany 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in United Kingdom 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in France 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in Italy 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in Spain 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in Benelux 2013-2017 Table Demand Volume of Angiotensin II Receptor by Downstream Industry in Russia 2013-2017 Table Demand Volume Forecast of Angiotensin II Receptor in Europe by Downstream Industry 2018-2023 Table Sales Volume of Angiotensin II Receptor in Europe by Major Players 2013-2017 Table Revenue of Angiotensin II Receptor in Europe by Major Players 2013-2017 Table Headquarters Location and Established Time of Angiotensin II Receptor Major Players Table Employees and Revenue Level of Angiotensin II Receptor Major Players Table Representative Angiotensin II Receptor Product One of CJ HealthCare Corp Table Representative Angiotensin II Receptor Product Two of CJ HealthCare Corp Table Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of CJ HealthCare Corp 2013-2017 Table Representative Angiotensin II Receptor Product One of MorphoSys AG Table Representative Angiotensin II Receptor Product Two of MorphoSys AG Table Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of MorphoSys AG 2013-2017 Table Representative Angiotensin II Receptor Product One of Novartis AG Table Representative Angiotensin II Receptor Product Two of Novartis AG Table Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of Novartis AG 2013-2017 Table Representative Angiotensin II Receptor Product One of Vicore Pharma AB Table Representative Angiotensin II Receptor Product Two of Vicore Pharma AB Table Angiotensin II Receptor Sales, Revenue, Price and Gross Margin of Vicore Pharma AB 2013-2017